Gift Syna Kuriakose, Leaman Daniel P, Zhang Lei, Kim Arthur S, Zwick Michael B
Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, California, USA.
Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, California, USA
J Virol. 2017 Nov 30;91(24). doi: 10.1128/JVI.01216-17. Print 2017 Dec 15.
The trimeric envelope glycoprotein spike (Env) of HIV-1 is the target of vaccine development to elicit broadly neutralizing antibodies (bnAbs). Env trimer instability and heterogeneity in principle make subunit interfaces inconsistent targets for the immune response. Here, we investigate how functional stability of Env relates to neutralization sensitivity to V2 bnAbs and V3 crown antibodies that engage subunit interfaces upon binding to unliganded Env. Env heterogeneity was inferred when antibodies neutralized a mutant Env with a plateau of less than 100% neutralization. A statistically significant correlation was found between the stability of mutant Envs and the MPN of V2 bnAb, PG9, as well as an inverse correlation between stability of Env and neutralization by V3 crown antibody, 447-52D. A number of Env-stabilizing mutations and V2 bnAb-enhancing mutations were identified in Env, but they did not always overlap, indicating distinct requirements of functional stabilization versus antibody recognition. Blocking complex glycosylation of Env affected V2 bnAb recognition, as previously described, but also notably increased functional stability of Env. This study shows how instability and heterogeneity affect antibody sensitivity of HIV-1 Env, which is relevant to vaccine design involving its dynamic apex. The Env trimer is the only viral protein on the surface of HIV-1 and is the target of neutralizing antibodies that reduce viral infectivity. Quaternary epitopes at the apex of the spike are recognized by some of the most potent and broadly neutralizing antibodies to date. Being that their glycan-protein hybrid epitopes are at subunit interfaces, the resulting heterogeneity can lead to partial neutralization. Here, we screened for mutations in Env that allowed for complete neutralization by the bnAbs. We found that when mutations outside V2 increased V2 bnAb recognition, they often also increased Env stability-of-function and decreased binding by narrowly neutralizing antibodies to the V3 crown. Three mutations together increased neutralization by V2 bnAb and eliminated binding by V3 crown antibodies. These results may aid the design of immunogens that elicit antibodies to the trimer apex.
HIV-1的三聚体包膜糖蛋白刺突(Env)是引发广泛中和抗体(bnAbs)的疫苗开发靶点。Env三聚体的不稳定性和异质性原则上使亚基界面成为免疫反应不一致的靶点。在此,我们研究Env的功能稳定性如何与对V2 bnAbs和V3冠抗体的中和敏感性相关,这些抗体在与未结合配体的Env结合时与亚基界面相互作用。当抗体中和突变型Env且中和平台低于100%时,推断存在Env异质性。发现突变型Env的稳定性与V2 bnAb PG9的中和潜力净值之间存在统计学显著相关性,以及Env稳定性与V3冠抗体447-52D的中和之间存在负相关。在Env中鉴定出许多Env稳定突变和V2 bnAb增强突变,但它们并不总是重叠,表明功能稳定与抗体识别有不同要求。如前所述,阻断Env的复杂糖基化会影响V2 bnAb识别,但也显著增加了Env的功能稳定性。本研究表明不稳定性和异质性如何影响HIV-1 Env的抗体敏感性,这与涉及其动态顶端的疫苗设计相关。Env三聚体是HIV-1表面唯一的病毒蛋白,是降低病毒感染性的中和抗体的靶点。刺突顶端的四级表位被一些迄今为止最有效且广泛中和的抗体识别。由于它们的聚糖-蛋白杂交表位位于亚基界面,由此产生的异质性可导致部分中和。在此,我们筛选了Env中允许bnAbs完全中和的突变。我们发现,当V2以外的突变增加V2 bnAb识别时,它们通常也会增加Env的功能稳定性,并减少窄谱中和抗体与V3冠的结合。三个突变共同增加了V2 bnAb的中和作用,并消除了V3冠抗体的结合。这些结果可能有助于设计能引发针对三聚体顶端抗体的免疫原。